Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
A Phase II Study of Cabozantinib (XL184) for Plexiform Neurofibromas in Subjects With Neurofibromatosis Type 1 in Children and Adults A Phase II Study of Cabozantinib(XL184) for Plexiform Neurofibromas in Subjects With Neurofibromatos ...